Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

[Current state of resistance of E. coli to trimethoprim in uncomplicated urinary tract infections in France].

Mabboux P, Rouveix B.

Prog Urol. 2019 Dec;29(16):943-946. doi: 10.1016/j.purol.2019.09.003. Epub 2019 Nov 19. French.

PMID:
31757712
2.

[Triclocarban antibacterial activity on resistant staphylococci, streptococci, and enterococci].

Drugeon HB, Rouveix B, Michaud-Nerard A.

Med Mal Infect. 2012 Jun;42(6):276-9. doi: 10.1016/j.medmal.2012.04.004. Epub 2012 May 22. French.

PMID:
22626523
3.

Effectiveness of antibiotics for acute sinusitis in real-life medical practice.

Blin P, Blazejewski S, Lignot S, Lassalle R, Bernard MA, Jayles D, Théophile H, Bénichou J, Demeaux JL, Ebbo D, Franck J, Moride Y, Peyramond D, Rouveix B, Sturkenboom M, Gehanno P, Droz C, Moore N.

Br J Clin Pharmacol. 2010 Sep;70(3):418-28. doi: 10.1111/j.1365-2125.2010.03710.x.

4.

Carriage of CTX-M-15-producing Escherichia coli isolates among children living in a remote village in Senegal.

Ruppé E, Woerther PL, Diop A, Sene AM, Da Costa A, Arlet G, Andremont A, Rouveix B.

Antimicrob Agents Chemother. 2009 Jul;53(7):3135-7. doi: 10.1128/AAC.00139-09. Epub 2009 Apr 13.

5.

Clinical implications of multiple drug resistance efflux pumps of pathogenic bacteria.

Rouveix B.

J Antimicrob Chemother. 2007 Jun;59(6):1208-9.

PMID:
17507420
6.

[Clinically significant toxicity and tolerance of the main antibiotics used in lower respiratory tract infections].

Rouveix B.

Med Mal Infect. 2006 Nov-Dec;36(11-12):697-705. Epub 2006 Jul 28. Review. French.

PMID:
16876974
7.

Randomized comparison of serum teicoplanin concentrations following daily or alternate daily dosing in healthy adults.

Rouveix B, Jehl F, Drugeon H, Brumpt I, Caulin E.

Antimicrob Agents Chemother. 2004 Jul;48(7):2394-9.

8.

Antibiotic safety assessment.

Rouveix B.

Int J Antimicrob Agents. 2003 Mar;21(3):215-21. Review.

PMID:
12636981
9.

Classification of oral cephalosporins. A matter for debate.

Williams JD, Naber KG, Bryskier A, Høby N, Gould IM, Periti P, Giamarellou H, Rouveix B.

Int J Antimicrob Agents. 2001 Jun;17(6):443-50.

PMID:
11397613
10.

[Antibacterial activity of urine after administration of ofloxacin for 5 days].

Drugeon H, Veyries ML, Levacher M, Garnier M, Aymard G, Giroud JP, Rouveix B.

Therapie. 2000 Nov-Dec;55(6):691-7. French.

PMID:
11234464
11.

[Antibiogram Committee of the French Microbiology Society. Report 2000-2001].

Soussy CJ, Carret G, Cavallo JD, Chardon H, Chidiac C, Choutet P, Courvalin P, Dabernat H, Drugeon H, Dubreuil L, Goldstein F, Jarlier V, Leclercq R, Nicolas-Chanoine MH, Philippon A, Quentin C, Rouveix B, Sirot J.

Pathol Biol (Paris). 2000 Nov;48(9):832-71. French. No abstract available.

PMID:
11141919
12.

[Pharmacology of recombinant cytokines].

Rouveix B, Giroud JP.

Therapie. 2000 Jan-Feb;55(1):155-64. Review. French.

PMID:
10860019
13.

Control of staphylococcal adhesion to polymethylmethacrylate and enhancement of susceptibility to antibiotics by poloxamer 407.

Veyries ML, Faurisson F, Joly-Guillou ML, Rouveix B.

Antimicrob Agents Chemother. 2000 Apr;44(4):1093-6.

14.

[Drugs for respiratory tropism and pregnancy].

Rouveix B, Levacher M, Giroud JP.

Rev Pneumol Clin. 1999 Oct;55(5):338-43. Review. French.

PMID:
10637903
15.

Controlled release of vancomycin from poloxamer 407 gels.

Veyries ML, Couarraze G, Geiger S, Agnely F, Massias L, Kunzli B, Faurisson F, Rouveix B.

Int J Pharm. 1999 Dec 10;192(2):183-93.

PMID:
10567749
16.

[Treatment of different types of pain].

Rouveix B, Bauwens MC, Giroud JP.

Bull Acad Natl Med. 1999;183(5):889-901; discussion 901-3. Review. French.

PMID:
10464993
17.

Pharmacokinetic parameters and killing rates in serum of volunteers receiving amoxicillin, cefadroxil or cefixime alone or associated with niflumic acid or paracetamol.

Carsenti-Etesse H, Farinotti R, Durant J, Roger PM, De Salvador F, Bernard E, Rouveix B, Dellamonica P.

Eur J Drug Metab Pharmacokinet. 1998 Jul-Sep;23(3):357-66.

PMID:
9842977
18.

Effect of a single oral dose of two erythromycin ethylsuccinate formulations on gastric emptying in healthy volunteers: a scintigraphic study.

Delatour F, Le Guludec D, Caron F, Faurisson F, Torlotin JC, Rouveix B.

Fundam Clin Pharmacol. 1998;12(3):292-7.

PMID:
9646062
19.

Clinical pharmacology of cytokines.

Rouveix B.

Eur Cytokine Netw. 1997 Sep;8(3):291-3. No abstract available.

20.

The effect of drugs on the mortality of mice inoculated with Friend leukaemia virus or toxoplasma gondii.

Starec M, Sinet M, Kodym P, Rosina J, Fiserová A, Desforges B, Rouveix B.

Physiol Res. 1997;46(2):107-11.

PMID:
9727501
21.

Pharmacokinetics of a new oral formulation of amoxicillin.

Prevot MH, Jehl F, Rouveix B.

Eur J Drug Metab Pharmacokinet. 1997 Jan-Mar;22(1):47-52.

PMID:
9179560
22.

Effects of two oral erythromycin ethylsuccinate formulations on the motility of the small intestine in human beings.

Caron F, Bouaniche M, Delatour F, Ducrotte P, Torlotin JC, Denis P, Humbert G, Rouveix B.

Antimicrob Agents Chemother. 1996 Aug;40(8):1796-800.

23.

[Effects of morphine on murine infection with Friend retrovirus].

Rouveix B, Veyries ML.

Bull Acad Natl Med. 1995 May;179(5):1069-80. French.

PMID:
7583459
24.

Effects of morphine on the pathogenesis of murine Friend retrovirus infection.

Veyries ML, Sinet M, Desforges B, Rouveix B.

J Pharmacol Exp Ther. 1995 Feb;272(2):498-504.

PMID:
7853162
25.

Pharmacological basis of immunotherapy in autoimmune diseases.

Rouveix B, Blin O.

Clin Neuropharmacol. 1993 Apr;16(2):104-12. Review.

PMID:
8477406
26.
27.

Synergistic activity of azithromycin and pyrimethamine or sulfadiazine in acute experimental toxoplasmosis.

Derouin F, Almadany R, Chau F, Rouveix B, Pocidalo JJ.

Antimicrob Agents Chemother. 1992 May;36(5):997-1001.

28.
29.

Immune status and survival of opiate- and cocaine-treated mice infected with Friend virus.

Starec M, Rouveix B, Sinet M, Chau F, Desforges B, Pocidalo JJ, Lechat P.

J Pharmacol Exp Ther. 1991 Nov;259(2):745-50.

PMID:
1941622
30.

[Bismuth revisited in Helicobacter pylori gastro-duodenal infection].

Caron F, Rouveix B.

Therapie. 1991 Sep-Oct;46(5):393-8. French.

PMID:
1754987
31.

Anti-Toxoplasma effects of dapsone alone and combined with pyrimethamine.

Derouin F, Piketty C, Chastang C, Chau F, Rouveix B, Pocidalo JJ.

Antimicrob Agents Chemother. 1991 Feb;35(2):252-5.

32.
33.
34.

Mefloquine failure in child contracting falciparum malaria in West Africa.

Gay F, Binet MH, Bustos MD, Rouveix B, Danis M, Roy C, Gentilini M.

Lancet. 1990 Jan 13;335(8681):120-1. No abstract available.

PMID:
1967412
35.

[Good tolerance and absence of immunologic effects in mice treated with arsenic-rich thermal water].

Mercier P, Papon E, Van Den Berghe C, Drutel P, Rouveix B.

C R Seances Soc Biol Fil. 1990;184(2):164-74. French.

PMID:
2148901
36.

Effect of zinc on the immune status of zinc-depleted AIDS related complex patients.

Zazzo JF, Rouveix B, Rajagopalon P, Levacher M, Girard PM.

Clin Nutr. 1989 Oct;8(5):259-61.

PMID:
16837298
37.

Divided-dose kinetics of mefloquine in man.

Franssen G, Rouveix B, Lebras J, Bauchet J, Verdier F, Michon C, Bricaire F.

Br J Clin Pharmacol. 1989 Aug;28(2):179-84.

38.

Mefloquine and an acute brain syndrome.

Rouveix B, Bricaire F, Michon C, Franssen G, Lebras J, Bernard J, Ajana F, Vienne JL.

Ann Intern Med. 1989 Apr 1;110(7):577-8. No abstract available.

PMID:
2784297
39.

Amodiaquine-induced immune agranulocytosis.

Rouveix B, Coulombel L, Aymard JP, Chau F, Abel L.

Br J Haematol. 1989 Jan;71(1):7-11.

PMID:
2917131
40.

Amodiaquine-induced agranulocytosis: report of a case with in vitro studies of granulocyte-macrophage progenitor cells.

Aymard JP, Rouveix B, Ferry R, Janot C, May T, Legras B, Streiff F.

Acta Haematol. 1989;82(1):40-2.

PMID:
2505473
41.

Maprotiline and pulmonary alveolitis.

Salmeron S, Brenot F, Rain B, Peuchemaur M, Herve P, Simonneau G, Duroux P, Rouveix B.

Ann Intern Med. 1988 Nov 1;109(9):758-9. No abstract available.

PMID:
3190060
42.

[Beta lactam-induced neutropenia: toxic or immune mechanism?].

Rouveix B, Lassoued K, Regnier B.

Therapie. 1988 Oct-Dec;43(6):489-92. French. No abstract available.

PMID:
3227515
43.

[Sex hormones and cortisol levels in patients with acquired immunodeficiency syndrome].

Bricaire F, Rouveix B, Pignal R.

Presse Med. 1988 Sep 10;17(30):1540. French. No abstract available.

PMID:
2971946
44.

[Trial of 3 months' prolonged treatment with cyclosporin in AIDS].

Leport C, Levacher M, Michon C, Rey MA, Rouveix B, Jelazko P.

Presse Med. 1987 Dec 12;16(42):2127-8. French. No abstract available.

PMID:
2963288
45.

[Action of cephalosporins on T lymphocytes: the role of mediators].

Rouveix B, Chau F.

Pathol Biol (Paris). 1987 Dec;35(10 Pt 2):1450-3. French.

PMID:
2963995
46.

[Amodiaquine-induced agranulocytosis. Description of 4 cases and review of the literature].

Aymard JP, Rouveix B, Klein M, Groult F, May T, Ferry R, Netter P.

Therapie. 1987 Jul-Aug;42(4):359-64. Review. French. No abstract available.

PMID:
3317983
47.
48.
49.

[Effect of cyclosporin on the number of circulating lymphocytes and T lymphocyte subpopulations in AIDS].

Leport C, Matheron S, Martin S, Katlama C, Gougerot-Pocidalo MA, Rouveix B, Brun-Vezinet F.

Presse Med. 1986 Nov 29;15(42):2118-9. French. No abstract available.

PMID:
2954056
50.

[Agranulocytosis and aprindine].

Rouveix B, Lassoued K, Abel L, Regnier B.

Therapie. 1986 Nov-Dec;41(6):517-8. French. No abstract available.

PMID:
3810547

Supplemental Content

Loading ...
Support Center